
Recent advances in understanding the relation of risk factors to coronary artery disease zzso have initiated a change in the approach to managing the zzso zzso Reduction of elevated blood pressure still remains a major therapeutic zzso However, the risk of cardiovascular morbidity is also related to zzso zzso zzso zzso and zzso all aggravate the risk of zzso in the patient with high blood zzso zzso is also zzso cigarette smoking, high alcohol consumption and lack of physical exercise all zzso to precocious zzso zzso Thus, the most favorable prognosis in terms of reducing zzso risk is accomplished by reducing elevated systemic zzso pressure while simultaneously improving all other risk zzso The method by which blood pressure is lowered is an important zzso The ancillary zzso activities of zzso drugs now available differ zzso zzso and beta blockers, for example, have potentially adverse zzso effects, whereas agents such as selective alpha zzso zzso appear to zzso affect several zzso zzso influencing the zzso risk zzso The impact of such drug-induced zzso changes on overall prognosis of the zzso patient remains to be zzso In the absence of other zzso however, it is sensible to use drugs that do not increase the zzso zzso to precocious zzso 

